{"DataElement":{"publicId":"3317616","version":"1","preferredName":"Invasive Ductal Breast Carcinoma In Situ Extent Category","preferredDefinition":"Text description and numeric percentage of the extent of DCIS associated with invasive cancer.","longName":"2191998v1.0:3316578v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2191998","version":"1","preferredName":"Invasive DCIS Diagnosis","preferredDefinition":"information related to a diagnosis of invasive ductal carcinoma in situ (DCIS).","longName":"INV_DCIS_DX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206786","version":"1","preferredName":"Invasive DCIS","preferredDefinition":"marked by a tendency to spread especially into healthy tissue.:Ductal carcinoma in situ (DCIS) is a carcinoma entirely confined to the mammary ducts.  There is no evidence of invasion of the basement membrane.  Currently, DCIS is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS. --2002","longName":"C14159:C2924","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-046C-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177541","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"Diagnosis","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C6-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8A00029-A756-68CD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3316578","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Extent Category","preferredDefinition":"A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS._The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._Category; used informally to mean a class of things.","longName":"3316578v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"6","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">50% of invasive cancer associated with DCIS","valueDescription":">50% of invasive cancer associated with DCIS","ValueMeaning":{"publicId":"3316579","version":"1","preferredName":">50% of invasive cancer associated with DCIS","longName":"3316579","preferredDefinition":">50% of invasive cancer associated with DCIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-628F-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2F49DDF-A98A-C6D5-E040-BB89AD4350E8","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-30","modifiedBy":"ONEDATA","dateModified":"2011-11-30","deletedIndicator":"No"},{"value":"Between 1 - 50% of invasive cancer associated with DCIS","valueDescription":"Between 1 - 50% of invasive cancer associated with DCIS","ValueMeaning":{"publicId":"3316580","version":"1","preferredName":"Between 1 - 50% of invasive cancer associated with DCIS","longName":"3316580","preferredDefinition":"Between 1 - 50% of invasive cancer associated with DCIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-62B2-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-62CB-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"Absent","valueDescription":"Absent","ValueMeaning":{"publicId":"2566329","version":"1","preferredName":"Absent","longName":"2566329","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D026-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-05","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-08-05","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-62D5-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3316612","version":"1","preferredName":"Ductal Breast Carcinoma In Situ Extent Category","preferredDefinition":"A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.:Category; used informally to mean a class of things.","longName":"C2924:C25332:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2F49DDF-AA5B-C6D5-E040-BB89AD4350E8","latestVersionIndicator":"Yes","beginDate":"2011-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-30","modifiedBy":"ONEDATA","dateModified":"2011-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6278-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"COOPERM","dateModified":"2011-12-14","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"DCIS component","type":"Preferred Question Text","description":"DCIS component","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2FAF830-B51C-7EBA-E040-BB89AD435EDC","latestVersionIndicator":"Yes","beginDate":"2011-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-30","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}